Assessment of regulatory T-cell function in forthcoming clinical trials of cell therapy

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

King’s College London and Guy’s and St Thomas’ NHS Foundation Trust have a strategic partnership with BD Biosciences in the context of the National Institute for Health Research Biomedical Research Center that seeks to translate advances in scientific discovery for the benefit of patients. The authors were supported by the NIHR (JB Canavan, B Afzali and GM Lord), Medical Research Council (B Afzali and G Lombardi), the British Heart Foundation (G Lombardi), the Academy of Medical Sciences (B Afzali), Wellcome Trust (B Afzali), and Guy’s and St Thomas’ Charity (JB Canavan, GM Lord and G Lombardi). Research was also supported by the NIHR Biomedical Research Center based at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.